Preventable Sight Loss

Mark Hendrick Excerpts

Tuesday 30th April 2024 Westminster Hall

[John McDonnell (Hayes and Harlington) (Lab)]

I congratulate my hon. Friend the Member for Wirral West (Margaret Greenwood) on securing this debate. That was a comprehensive and detailed, but succinct, assessment of where we are at. Sometimes, the role of Members of Parliament is to identify an issue before it comes into crisis so that we can advise Government on the action that is needed, and that is exactly what my hon. Friend has done.

When some of my constituents identified this topic as the subject of an Adjournment debate, they approached me to raise an issue I have been dealing with for the last 20 years: people whose eyesight has been damaged as a result of refractive eye surgery, or laser treatment, as some know it. The refractive eye surgery sector is now a huge profit-making industry. Many gain through the use of refractive eye surgery, and their eyesight is benefited, but there are many others—in fact, thousands every year now—whose vision is damaged as a result of the surgery.

Many years ago, a campaign called My Beautiful Eyes was launched by a woman called Sasha Rodoy. Some people will know of her if they have dealt with these laser treatment issues in any way. She is a heroine. Each year, we organise a lobby of Parliament called Bad Eye Day. We bring together individuals whose eyesight has been damaged by refractive eye surgery and their families. When I say “damaged”, for many of them, it is to the point where their eyesight is nearly lost. Many others have heartbreaking stories of losing their employment or being severely disabled.

In 2004, Frank Cook, who was then a Labour MP, introduced a private Member’s Bill to address the issues confronting people whose eyesight had been damaged by refractive eye surgery. I co-sponsored the Bill, which basically called for regulation of the sector. In 2013, I produced a ten-minute rule Bill that reflected many of the proposals that Frank had put forward. We have had debates, meetings with the royal colleges and ministerial meetings. All we have been asking for over the past 20 years is greater regulation—effective regulation—but progress has been limited. Even in the Government’s own inquiry into cosmetic surgery, Sir Bruce Keogh identified laser surgery as something that should be subject to further regulation. To be frank, nothing has followed from all those ministerial meetings and debates, from all the legislation we put forward or from the Government’s own inquiry.

We need effective regulation that runs through every aspect of the process. The first aspect is the marketing and advertising of these treatments. As Sasha Rodoy says, the industry is notorious for making outlandish claims about the effectiveness of surgery. On a few occasions, we have taken companies to the Advertising Standards Authority and they have been found guilty of exaggerating their claims about the treatment.

Secondly, we want regulation of the advice provided to people who commission the surgery. It is about getting appropriate advice, and about whether the individual’s eye is appropriate for the type of surgery. At one stage, we found that advice was being provided by members of staff who were not qualified and were simply selling the product. We want the provision of advice to be regulated, supervised and monitored.

We also want surgical practices and professional standards to be supervised and monitored. I have dealt with several cases in which professional standards have fallen below what we would expect and people have been harmed as a result. When things go wrong, the company will often fail to put things right adequately. It will delay its response and will often try to get beyond the limit when legal action can be taken. Those individuals then have to fall back on the NHS.

Time and again, the NHS has to address complex injuries as a result of laser treatment, yet the financial burden falls not on the companies but on the NHS itself. We have argued that the performance records of those private companies and, if necessary, of the surgeons involved should be published to identify where harm has been caused as a result of action taken. Where NHS involvement is needed to correct or address the concerns that people have been left with, maybe there should be a levy on those private companies so that the cost burden does not fall on the NHS.

We are now 20 years on from that first piece of legislation, which Frank Cook brought forward because—if I recall rightly—he had gone through that experience and was interviewed by the media about it. All of a sudden, he received a flood of correspondence from people saying, “The same thing’s happened to me: I’ve had the same sort of injuries.” When I raised the issue in 2013, I had literally hundreds of emails coming in. We have a national lobby each time, and some of the stories are absolutely heartbreaking.

I know that there are demands on the Minister’s time, but it would be really useful if, like some of his predecessors, he met victims of refractive eye surgery who have become campaigners and the professionals they work with, so that we can address the current situation, get an objective overview of where we are and then agree a programme for reform. All that people are asking for is adequate regulation based on monitoring of professional practices, so that they feel protected. At the moment, as my hon. Friend the Member for Wirral West said, there is a real risk of eyesight loss. It is one of the worst things that can happen to people, because they become completely isolated from the world. It is incredibly distressing.

That request fits with the demand for a national eyesight strategy, which is desperately needed. What my hon. Friend described is happening across the country. There is a fear that if we do not address it now, we could quickly get into a crisis as a result of the loss of professional staff to the NHS in particular. My hon. Friend the Member for Leeds North West (Alex Sobel) also mentioned the postcode lottery of access to those services. I hope that the Minister will agree to meet campaigners on this issue, which is worth addressing, so that at least they can have their say and he can take advice on the programme of reform that we need.

[Sir Mark Hendrick (in the Chair)]

We now move to the Front-Bench contributions.

--- Later in debate ---

[Andrew Stephenson]

I thank the right hon. Gentleman for making those points. I am not instinctively anti-regulation; indeed, just a few weeks ago I put through this place the statutory instrument on the regulation of physician associates and anaesthetist associates. There are certain parts of the healthcare sector where regulation is very much needed and I would very much advocate for it. As I have said, I will defer to my right hon. Friend the Member for South Northamptonshire. This is her ministerial responsibility, and I am sure she will read the right hon. Gentleman’s comments with interest and may want to take the discussions further.

Finally, on research, the Government are backing scientists and researchers to take strides in understanding sight loss and in making new treatments available. Two years ago, we awarded £20 million to Moorfields Biomedical Research Centre to undertake another five years of vision research, and almost £6.5 million to Moorfields Clinical Research Facility to support cutting-edge treatments for all eye conditions.

Eye care services face challenges and we are taking decisive action to address them, both now and in the long term. The hon. Member for Wirral West and I will never agree on the use of the independent sector. I strongly believe, and think the Labour Front Bench team strongly agrees, that using the independent sector enables us to fully realise our healthcare system’s capacity and to reduce the time that patients spend on waiting lists. I would argue that that does not represent any move to privatise our NHS. As I have said on the record before, the overall proportion of NHS England’s spend on independent sector providers has not increased significantly in recent years. In 2013-14, 6.1% of total health spending was spent on the purchase of healthcare from independent sector providers; in 2022-23, the proportion was 6.5%.

This morning, the shadow Minister in the first Westminster Hall debate, the hon. Member for Denton and Reddish (Andrew Gwynne), talked about making better use of the independent sector to help to ensure that we deliver the best outcomes for patients, and the shadow Minister in this debate, the hon. Member for Birmingham, Edgbaston, reiterated that point. On the use of the independent sector, then, I gently say that it is something on which there is broad cross-party support. While recognising that there are always challenges with the use of the independent sector, it is not in any way a privatisation of the NHS.

I firmly believe that through prevention, innovation and investment in our workforce, we will deliver for all our people across the United Kingdom access to the important healthcare services, including ophthalmology services, that they deserve.

[Sir Mark Hendrick (in the Chair)]

I call Margaret Greenwood to wind up the debate.